Furthermore, the GSTM1, GSTT1, and/or GSTP1 Ile105Val polymorphisms were associated with variable survival in HNSCC patients treated with CDDP chemoradiation15 or RT16. This evidence concerns the gene GSTP1 and head and neck squamous cell carcinoma.